CVE-2026-84302 - Discourse: Non-participant moderators can read, edit, and delete PM content through Discourse AI reviewables
CVE ID :CVE-2026-84302
Published : Sept. 24, 2026, 4:49 p.m. | 21 minutes ago
Description :Discourse is an open-source discussion platform. Prior to 2026.1.6, 2026.5.2, 2026.6.1, and 2026.7.0, Discourse AI reviewables associated with private messages could appear in the moderator review queue of a moderator who was not a participant in the message. Reviewable visibility filtering did not restrict private-message reviewables to the audience permitted to access the underlying private-message topic, allowing the moderator to read otherwise confidential content. Depending on the available reviewable action, the moderator could also modify the private message by closing its topic or deleting a post. Exploitation requires an authenticated moderator account and a pre-existing Discourse AI reviewable associated with a private message. This issue is fixed in versions 2026.1.6, 2026.5.2, 2026.6.1, and 2026.7.0.
Severity: 0.0 | NA
Visit the link for more details, such as CVSS details, affected products, timeline, and more...
Published : Sept. 24, 2026, 4:49 p.m. | 21 minutes ago
Description :Discourse is an open-source discussion platform. Prior to 2026.1.6, 2026.5.2, 2026.6.1, and 2026.7.0, Discourse AI reviewables associated with private messages could appear in the moderator review queue of a moderator who was not a participant in the message. Reviewable visibility filtering did not restrict private-message reviewables to the audience permitted to access the underlying private-message topic, allowing the moderator to read otherwise confidential content. Depending on the available reviewable action, the moderator could also modify the private message by closing its topic or deleting a post. Exploitation requires an authenticated moderator account and a pre-existing Discourse AI reviewable associated with a private message. This issue is fixed in versions 2026.1.6, 2026.5.2, 2026.6.1, and 2026.7.0.
Severity: 0.0 | NA
Visit the link for more details, such as CVSS details, affected products, timeline, and more...